Global Blood Therapeutics, Inc.
MODULATORS OF HEMOGLOBIN
Last updated:
Abstract:
The present disclosure relates generally to compounds and pharmaceutical compositions suitable as modulators of hemoglobin, and methods for their use in treating disorders mediated by hemoglobin.
Status:
Application
Type:
Utility
Filling date:
4 May 2020
Issue date:
18 Feb 2021